Source link : https://newshealth.biz/health-news/barzolvolimab-showed-prolonged-clinical-efficacy-in-chronic-hives/
In this exclusive MedPage Today video, Jonathan Bernstein, MD, of the University of Cincinnati College of Medicine, discusses emerging data on barzolvolimab, an investigational humanized monoclonal antibody, in chronic spontaneous urticaria (CSU) presented at the American Academy of Allergy, Asthma & Immunology annual meeting. Study outcomes showed evidence that some patients maintained disease control even […]
The post Barzolvolimab Showed Prolonged Clinical Efficacy in Chronic Hives first appeared on News Health.
—-
Author : News Health
Publish date : 2026-03-16 17:51:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8